Anshita Goel

Transcriptomic profiling of tropomyosin isoforms in bladder cancer: multi-platform sequencing and experimental validation

mRNA isoform level-based biomarkers are understudied but might complement DNA based approaches. The expression of tropomyosin isoforms differs between normal and cancer cells. Tropomyosin (TPM) isoforms generated by alternative splicing may contribute to Bladder Cancer (BC) biolo...